FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3214765005> ?p ?o ?g. }

• W3214765005 endingPage "126" @default.
• W3214765005 startingPage "115" @default.
• W3214765005 abstract "Allogeneic cancer vaccines are designed to induce antitumor immune responses with the goal of impacting tumor growth. Typical allogeneic cancer vaccines are produced by expansion of established cancer cell lines, transfection with vectors encoding immunostimulatory cytokines, and lethal irradiation. More than 100 clinical trials have investigated the clinical benefit of allogeneic cancer vaccines in various cancer types. Results show limited therapeutic benefit in clinical trials and currently there are no FDA-approved allogeneic cancer vaccines. We used recently developed bioinformatics tools including the pVACseq suite of software tools to analyze DNA/RNA-sequencing data from the The Cancer Genome Atlas to examine the repertoire of antigens presented by a typical allogeneic cancer vaccine, and to simulate allogeneic cancer vaccine clinical trials. Specifically, for each simulated clinical trial, we modeled the repertoire of antigens presented by allogeneic cancer vaccines consisting of three hypothetical cancer cell lines to 30 patients with the same cancer type. Simulations were repeated ten times for each cancer type. Each tumor sample in the vaccine and the vaccine recipient was subjected to human leukocyte antigen (HLA) typing, differential expression analyses for tumor-associated antigens (TAA), germline variant calling, and neoantigen prediction. These analyses provided a robust, quantitative comparison between potentially beneficial TAAs and neoantigens versus distracting antigens present in the allogeneic cancer vaccines. We observe that distracting antigens greatly outnumber shared TAAs and neoantigens, providing one potential explanation for the lack of observed responses to allogeneic cancer vaccines. This analysis provides additional rationale for the redirection of efforts toward a personalized cancer vaccine approach. Significance: A comprehensive examination of allogeneic cancer vaccine antigen repertoire using large-scale genomics datasets highlights the large number of distracting antigens and argues for more personalized approaches to immunotherapy that leverage recent strategies in tumor antigen identification." @default.
• W3214765005 created "2021-12-06" @default.
• W3214765005 creator A5001076376 @default.
• W3214765005 creator A5014356331 @default.
• W3214765005 creator A5017692700 @default.
• W3214765005 creator A5020521476 @default.
• W3214765005 creator A5037906844 @default.
• W3214765005 creator A5046293210 @default.
• W3214765005 creator A5049794515 @default.
• W3214765005 creator A5049964541 @default.
• W3214765005 creator A5052134884 @default.
• W3214765005 creator A5060050760 @default.
• W3214765005 creator A5061051284 @default.
• W3214765005 creator A5061892063 @default.
• W3214765005 date "2021-11-30" @default.
• W3214765005 modified "2023-10-16" @default.
• W3214765005 title "<i>In Silico</i> Epitope Prediction Analyses Highlight the Potential for Distracting Antigen Immunodominance with Allogeneic Cancer Vaccines" @default.
• W3214765005 cites W1518475556 @default.
• W3214765005 cites W1563231374 @default.
• W3214765005 cites W1848613573 @default.
• W3214765005 cites W1941630149 @default.
• W3214765005 cites W1966916002 @default.
• W3214765005 cites W1969194497 @default.
• W3214765005 cites W1983806918 @default.
• W3214765005 cites W1988065950 @default.
• W3214765005 cites W1992699637 @default.
• W3214765005 cites W1993642299 @default.
• W3214765005 cites W2021896163 @default.
• W3214765005 cites W2041146480 @default.
• W3214765005 cites W2067712862 @default.
• W3214765005 cites W2104401164 @default.
• W3214765005 cites W2109488005 @default.
• W3214765005 cites W2119180969 @default.
• W3214765005 cites W2128542677 @default.
• W3214765005 cites W2133514770 @default.
• W3214765005 cites W2137158234 @default.
• W3214765005 cites W2142386149 @default.
• W3214765005 cites W2148146008 @default.
• W3214765005 cites W2149992227 @default.
• W3214765005 cites W2150056019 @default.
• W3214765005 cites W2152061559 @default.
• W3214765005 cites W2156480430 @default.
• W3214765005 cites W2157939496 @default.
• W3214765005 cites W2158485828 @default.
• W3214765005 cites W2163188200 @default.
• W3214765005 cites W2177083469 @default.
• W3214765005 cites W2256496883 @default.
• W3214765005 cites W2320008710 @default.
• W3214765005 cites W2521492299 @default.
• W3214765005 cites W2552158984 @default.
• W3214765005 cites W2599193869 @default.
• W3214765005 cites W2623410148 @default.
• W3214765005 cites W2728365508 @default.
• W3214765005 cites W2768599330 @default.
• W3214765005 cites W2771729549 @default.
• W3214765005 cites W2790225801 @default.
• W3214765005 cites W2888632026 @default.
• W3214765005 cites W2900010829 @default.
• W3214765005 cites W2976596814 @default.
• W3214765005 cites W2982049472 @default.
• W3214765005 cites W2982321167 @default.
• W3214765005 cites W2998313390 @default.
• W3214765005 cites W3009851126 @default.
• W3214765005 cites W3046115489 @default.
• W3214765005 cites W3095860059 @default.
• W3214765005 cites W4205247356 @default.
• W3214765005 cites W4236294751 @default.
• W3214765005 doi "https://doi.org/10.1158/2767-9764.crc-21-0029" @default.
• W3214765005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35611186" @default.
• W3214765005 hasPublicationYear "2021" @default.
• W3214765005 type Work @default.
• W3214765005 sameAs 3214765005 @default.
• W3214765005 citedByCount "0" @default.
• W3214765005 crossrefType "journal-article" @default.
• W3214765005 hasAuthorship W3214765005A5001076376 @default.
• W3214765005 hasAuthorship W3214765005A5014356331 @default.
• W3214765005 hasAuthorship W3214765005A5017692700 @default.
• W3214765005 hasAuthorship W3214765005A5020521476 @default.
• W3214765005 hasAuthorship W3214765005A5037906844 @default.
• W3214765005 hasAuthorship W3214765005A5046293210 @default.
• W3214765005 hasAuthorship W3214765005A5049794515 @default.
• W3214765005 hasAuthorship W3214765005A5049964541 @default.
• W3214765005 hasAuthorship W3214765005A5052134884 @default.
• W3214765005 hasAuthorship W3214765005A5060050760 @default.
• W3214765005 hasAuthorship W3214765005A5061051284 @default.
• W3214765005 hasAuthorship W3214765005A5061892063 @default.
• W3214765005 hasBestOaLocation W32147650051 @default.
• W3214765005 hasConcept C121608353 @default.
• W3214765005 hasConcept C126322002 @default.
• W3214765005 hasConcept C147483822 @default.
• W3214765005 hasConcept C195616568 @default.
• W3214765005 hasConcept C203014093 @default.
• W3214765005 hasConcept C2777701055 @default.
• W3214765005 hasConcept C2778378633 @default.
• W3214765005 hasConcept C2780674031 @default.
• W3214765005 hasConcept C535046627 @default.
• W3214765005 hasConcept C71924100 @default.
• W3214765005 hasConcept C86803240 @default.

• next